| Mechanisms of antigen escape from BCMA-or GPRC5D-targeted immunotherapies in multiple myeloma H Lee, S Ahn, R Maity, N Leblay, B Ziccheddu, M Truger, M Chojnacka, ... Nature medicine 29 (9), 2295-2306, 2023 | 76 | 2023 |
| Single-cell profiling of tumour evolution in multiple myeloma—opportunities for precision medicine AK Dutta, JB Alberge, R Sklavenitis-Pistofidis, ED Lightbody, G Getz, ... Nature Reviews Clinical Oncology 19 (4), 223-236, 2022 | 75 | 2022 |
| Prevalence of monoclonal gammopathies and clinical outcomes in a high-risk US population screened by mass spectrometry: a multicentre cohort study H El-Khoury, DJ Lee, JB Alberge, R Redd, CJ Cea-Curry, J Perry, H Barr, ... The Lancet Haematology 9 (5), e340-e349, 2022 | 37 | 2022 |
| Single cell characterization of myeloma and its precursor conditions reveals transcriptional signatures of early tumorigenesis R Boiarsky, NJ Haradhvala, JB Alberge, R Sklavenitis-Pistofidis, ... Nature Communications 13 (1), 7040, 2022 | 31 | 2022 |
| Increased antitumor efficacy of PD-1-deficient melanoma-specific human lymphocytes L Marotte, S Simon, V Vignard, E Dupre, M Gantier, J Cruard, JB Alberge, ... Journal for Immunotherapy of Cancer 8 (1), 2020 | 30 | 2020 |
| MinimuMM-seq: genome sequencing of circulating tumor cells for minimally invasive molecular characterization of multiple myeloma pathology AK Dutta, JB Alberge, ED Lightbody, CJ Boehner, A Dunford, ... Cancer discovery 13 (2), 348-363, 2023 | 12 | 2023 |
| Mutations and copy number gains of the BCL2 family members mediate resistance to venetoclax in multiple myeloma (MM) patients P Neri, R Maity, JB Alberge, S Sinha, J Donovan, M Kong, F Hasan, ... Blood 134, 572, 2019 | 10 | 2019 |
| DNA hydroxymethylation is associated with disease severity and persists at enhancers of oncogenic regions in multiple myeloma JB Alberge, F Magrangeas, M Wagner, S Denié, C Guérin-Charbonnel, ... Clinical Epigenetics 12, 1-12, 2020 | 9 | 2020 |
| Molecular signature of 18F-FDG PET biomarkers in newly diagnosed multiple myeloma patients: a genome-wide transcriptome analysis from the CASSIOPET study JB Alberge, F Kraeber-Bodéré, B Jamet, C Touzeau, H Caillon, ... Journal of Nuclear Medicine 63 (7), 1008-1013, 2022 | 8 | 2022 |
| Integrated epigenetic and transcriptional single-cell analysis of t (11; 14) multiple myeloma and its BCL2 dependency N Leblay, S Ahn, R Tilmont, M Poorebrahim, R Maity, H Lee, E Barakat, ... Blood 143 (1), 42-56, 2024 | 5 | 2024 |
| Prevalence of monoclonal gammopathies and clinical outcomes in a high-risk US population screened by mass spectrometry: A prospective cohort study H El-Khoury, DJ Lee, JB Alberge, R Redd, CJ Cea-Curry, J Perry, H Barr, ... | 5 | 2021 |
| High prevalence of monoclonal gammopathy in a population at risk: the first results of the Promise study H El-Khoury, JB Alberge, H Barr, C Murphy, DJ Sakrikar, T Krause, ... Blood 138, 152, 2021 | 5 | 2021 |
| A p53 score derived from TP53 CRISPR/Cas9 HMCLs predicts survival and reveals a major role of BAX in the response to BH3 mimetics R Durand, G Descamps, C Bellanger, C Dousset, S Maïga, JB Alberge, ... Blood 143 (13), 1242-1258, 2024 | 4 | 2024 |
| Mass spectrometry-detected MGUS is associated with obesity and other novel modifiable risk factors in a high-risk population DJ Lee, H El-Khoury, AC Tramontano, JB Alberge, J Perry, MI Davis, ... Blood Advances 8 (7), 1737-1746, 2024 | 3 | 2024 |
| Expansion of effector memory CD27+ T cells and tolerogenic type 2 classical dendritic cells regulate myeloma patients’ sensitivity to daratumumab & IMiDs P Neri, JB Alberge, R Maity, S McCulloch, J Tay, V Jimenez-Zepeda, ... Clinical Lymphoma, Myeloma and Leukemia 19 (10), e29-e30, 2019 | 2 | 2019 |
| Exploring the impact of dexamethasone on gene regulation in myeloma cells V Bessonneau-Gaborit, J Cruard, C Guerin-Charbonnel, J Derrien, ... Life Science Alliance 6 (9), 2023 | 1 | 2023 |
| Tumor Intrinsic Mechanisms of Antigen Escape to Anti-BCMA and Anti-GPRC5D Targeted Immunotherapies in Multiple Myeloma N Bahlis, H Lee, S Ahn, R Maity, N Leblay, B Ziccheddu, M Chojnacka, ... | 1 | 2023 |
| Abnormal free light chains in individuals with African ancestry screened for monoclonal gammopathy: definition of new reference range accounting for renal function and race L Bertamini, JB Alberge, H El-Khoury, DJ Lee, C Murphy, G Fleming, ... Blood 140 (Supplement 1), 10005-10006, 2022 | 1 | 2022 |
| Persistence of Monoclonal Gammopathies in Serial Samples from a US Population-Based Screening Study H El-Khoury, L Bertamini, JB Alberge, DJ Lee, C Murphy, G Fleming, ... Blood 140 (Supplement 1), 10101-10103, 2022 | 1 | 2022 |
| Single-cell RNA sequencing of rare circulating tumor cells in precursor myeloma patients reveals molecular underpinnings of tumor cell circulation ED Lightbody, DT Firer, R Sklavenitis-Pistofidis, J Tsuji, MP Agius, ... Blood 140 (Supplement 1), 602-603, 2022 | 1 | 2022 |
